Analysed UNICYCIVE THERAPEUTICS INC (UNCY:NASDAQ) News Sources
Unicycive Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference
09-04-2026
yahoo.com
Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update
30-03-2026
yahoo.com
Unicycive Therapeutics to Participate in a Fireside Chat at Guggenheim’s Emerging Outlook: Biotech Summit
04-02-2026
yahoo.com
UPDATE - Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate (OLC) New Drug Application (NDA) Resubmission
29-01-2026
yahoo.com
Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate (OLC) New Drug Application (NDA) Resubmission
29-01-2026
yahoo.com
Unicycive Therapeutics Announces Resubmission of New Drug Application (NDA) for Oxylanthanum Carbonate (OLC)
29-12-2025
yahoo.com
Companies Like Unicycive Therapeutics (NASDAQ:UNCY) Are In A Position To Invest In Growth
29-12-2025
yahoo.com
Retail investors who hold 48% of Unicycive Therapeutics, Inc. (NASDAQ:UNCY) gained 23%, institutions profited as well
18-11-2025
yahoo.com
What is the current price of UNICYCIVE THERAPEUTICS INC (UNCY:NASDAQ)?
The current price of UNICYCIVE THERAPEUTICS INC (UNCY:NASDAQ) is $7.68.
UNICYCIVE THERAPEUTICS INC (UNCY:NASDAQ) absolute price change since previous trading day?
The absolute price change of UNICYCIVE THERAPEUTICS INC (UNCY:NASDAQ) since the previous trading day is $0.47.
UNICYCIVE THERAPEUTICS INC (UNCY:NASDAQ) percentage price change since previous trading day?
The percentage price change of UNICYCIVE THERAPEUTICS INC (UNCY:NASDAQ) since the previous trading day is 6.5187%.
What is the most recent average sentiment score for UNICYCIVE THERAPEUTICS INC (UNCY:NASDAQ)?
The most recent average sentiment score for UNICYCIVE THERAPEUTICS INC (UNCY:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for UNICYCIVE THERAPEUTICS INC (UNCY:NASDAQ)?
The most recent sentiment for UNICYCIVE THERAPEUTICS INC (UNCY:NASDAQ) is .
SEC-8K** Filing Available For UNICYCIVE THERAPEUTICS INC (UNCY:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.